批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2017/04/06 |
SUPPL-31(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2015/08/14 |
SUPPL-30(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2011/09/30 |
SUPPL-28(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2006/06/05 |
SUPPL-27(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2003/12/22 |
SUPPL-26(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2002/07/26 |
SUPPL-24(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2001/12/07 |
SUPPL-22(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2001/12/04 |
SUPPL-23(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2000/03/02 |
SUPPL-21(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2000/03/02 |
SUPPL-20(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1998/08/14 |
SUPPL-17(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1998/04/22 |
SUPPL-14(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1998/03/18 |
SUPPL-19(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1997/06/22 |
SUPPL-18(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1997/05/16 |
SUPPL-13(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1996/12/02 |
SUPPL-16(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1996/12/02 |
SUPPL-15(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1995/07/10 |
SUPPL-12(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1995/01/18 |
SUPPL-11(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1993/12/09 |
SUPPL-9(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1993/03/25 |
SUPPL-6(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1992/05/21 |
SUPPL-5(补充) |
Approval |
Labeling |
|
|
|
1992/05/21 |
SUPPL-4(补充) |
Approval |
Labeling |
|
|
|
1990/07/09 |
SUPPL-3(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1989/08/09 |
SUPPL-1(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1986/11/05 |
ORIG-1(原始申请) |
Approval |
Type 3 - New Dosage Form |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:TIMOLOL MALEATE 剂型/给药途径:SOLUTION/DROPS;OPHTHALMIC 规格:EQ 0.25% BASE 治疗等效代码:AT3
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
019463 |
001 |
NDA |
TIMOPTIC IN OCUDOSE |
TIMOLOL MALEATE |
SOLUTION/DROPS;OPHTHALMIC |
EQ 0.25% BASE |
Prescription |
Yes |
Yes |
AT3 |
1986/11/05
|
BAUSCH AND LOMB INC |
212592 |
001 |
ANDA |
TIMOLOL MALEATE |
TIMOLOL MALEATE |
SOLUTION/DROPS;OPHTHALMIC |
EQ 0.25% BASE |
Prescription |
No |
No |
AT3 |
2021/12/13
|
AMRING PHARMS |
216533 |
001 |
ANDA |
TIMOLOL MALEATE |
TIMOLOL MALEATE |
SOLUTION/DROPS;OPHTHALMIC |
EQ 0.25% BASE |
Prescription |
No |
No |
AT3 |
2022/09/13
|
INGENUS PHARMS LLC |
活性成分:TIMOLOL MALEATE 剂型/给药途径:SOLUTION/DROPS;OPHTHALMIC 规格:EQ 0.5% BASE 治疗等效代码:AT3
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
019463 |
002 |
NDA |
TIMOPTIC IN OCUDOSE |
TIMOLOL MALEATE |
SOLUTION/DROPS;OPHTHALMIC |
EQ 0.5% BASE |
Prescription |
Yes |
Yes |
AT3 |
1986/11/05
|
BAUSCH AND LOMB INC |
212291 |
001 |
ANDA |
TIMOLOL MALEATE |
TIMOLOL MALEATE |
SOLUTION/DROPS;OPHTHALMIC |
EQ 0.5% BASE |
Prescription |
No |
No |
AT3 |
2020/09/11
|
EPIC PHARMA LLC |
212592 |
002 |
ANDA |
TIMOLOL MALEATE |
TIMOLOL MALEATE |
SOLUTION/DROPS;OPHTHALMIC |
EQ 0.5% BASE |
Prescription |
No |
No |
AT3 |
2021/12/13
|
AMRING PHARMS |
216596 |
001 |
ANDA |
TIMOLOL MALEATE |
TIMOLOL MALEATE |
SOLUTION/DROPS;OPHTHALMIC |
EQ 0.5% BASE |
Prescription |
No |
No |
AT3 |
2022/09/07
|
MICRO LABS |
216533 |
002 |
ANDA |
TIMOLOL MALEATE |
TIMOLOL MALEATE |
SOLUTION/DROPS;OPHTHALMIC |
EQ 0.5% BASE |
Prescription |
No |
No |
AT3 |
2022/09/13
|
INGENUS PHARMS LLC |
217195 |
001 |
ANDA |
TIMOLOL MALEATE |
TIMOLOL MALEATE |
SOLUTION/DROPS;OPHTHALMIC |
EQ 0.5% BASE |
Prescription |
No |
No |
AT3 |
2023/05/08
|
SENTISS PHARMA |